• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 4. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzisoxazoles

Recent Advances in the Study of 1,2-Benzisoxazole,5-methoxy-3-methyl- (CAS: 145508-90-3) in Chemical Biology and Pharmaceutical Research

The compound 1,2-Benzisoxazole,5-methoxy-3-methyl- (CAS: 145508-90-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the role of 1,2-Benzisoxazole,5-methoxy-3-methyl- as a key intermediate in the synthesis of novel bioactive molecules. Its structural framework, characterized by a benzisoxazole core with methoxy and methyl substituents, has been shown to interact with various biological targets, including enzymes and receptors involved in neurological and inflammatory pathways. This has spurred interest in its potential as a scaffold for designing new drugs.

One of the most notable advancements in this area is the development of efficient synthetic routes for 1,2-Benzisoxazole,5-methoxy-3-methyl-. Researchers have reported improved yields and selectivity using catalytic methods, which are crucial for scaling up production for preclinical and clinical studies. Additionally, computational studies have provided insights into the compound's binding modes and interactions with target proteins, further guiding its optimization.

In terms of biological activity, recent in vitro and in vivo studies have demonstrated that derivatives of 1,2-Benzisoxazole,5-methoxy-3-methyl- exhibit promising pharmacological properties. For instance, some analogs have shown potent inhibitory effects on specific kinases and proteases, suggesting potential applications in treating cancers and autoimmune diseases. Moreover, the compound's metabolic stability and low toxicity profile make it an attractive candidate for further development.

Despite these promising findings, challenges remain in fully elucidating the compound's mechanism of action and optimizing its pharmacokinetic properties. Ongoing research is focused on addressing these gaps, with particular emphasis on structure-activity relationship (SAR) studies and the development of more potent and selective derivatives. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate progress in this area.

In conclusion, 1,2-Benzisoxazole,5-methoxy-3-methyl- (CAS: 145508-90-3) represents a versatile and promising compound in chemical biology and drug discovery. Its unique structural features and biological activities underscore its potential as a lead compound for developing novel therapeutics. Future research should prioritize translational studies to bridge the gap between laboratory findings and clinical applications, ultimately contributing to advancements in human health.

• 73344-39-5(1,2-BENZISOXAZOLE, 6-METHOXY-3-METHYL-)
• 214760-33-5(1,2-Benzisoxazol-7-ol, 3-methyl- (9CI))
• 66047-18-5(1,2-BENZISOXAZOLE, 6,6'-[1,5-PENTANEDIYLBIS(OXY)]BIS[3-METHYL-)
• 57148-91-1(2-(6-methoxybenzo[d]isoxazol-3-yl)ethanol)
• 63152-89-6(3-Methyl-5-[(oxiran-2-yl)methoxy]-1,2-benzoxazole)
• 214760-36-8(1,2-Benzisoxazol-5-ol, 3-methyl- (9CI))
• 145508-91-4(1,2-Benzisoxazole,7-methoxy-3-methyl-)
• 66047-16-3(1,2-BENZISOXAZOLE, 6,6'-[1,3-PROPANEDIYLBIS(OXY)]BIS[3-METHYL-)
• 66033-92-9(3-Methyl-1,2-benzisoxazol-6-ol)
• 51110-58-8(3-Methyl-benzodisoxazol-4-ol)